Exosens revenue and financials
€57.85Change from previous close: +2.12%Absolute change: +€1.20
In the fiscal year ended December 2025, Exosens reported revenue of €383.4M (−18.11% year over year). Net income was €30.7M, a net margin of 8.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −18.11%
- 2025 vs 2024
- Net income growth
- −28.10%
- 2025 vs 2024
- Net margin
- 8.0%
- 2024: 9.1%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 |
|---|---|---|---|
| Total assets | 895 | 879 | 867 |
| Current assets | 306 | 280 | 314 |
| Cash and equivalents | 68.8 | 68.6 | 89.8 |
| Short-term investments | 0.4 | 33.3 | — |
| Inventory | 123 | 105 | 106 |
| Net property, plant and equipment | 144 | 128 | 119 |
| Goodwill | 233 | 233 | 209 |
| Other intangible assets | 197 | 226 | 221 |
| Long-term investments | — | 3.8 | 3.4 |
| Current liabilities | 130 | 114 | 125 |
| Accounts payable | 35.6 | 31.2 | 30.9 |
| Long-term debt | 247 | — | 247 |
| Total debt | 265 | 16.6 | 266 |
| Total liabilities | 444 | 433 | 438 |
| Total equity (incl. minority) | 451 | 446 | 430 |